Purchase Order 75N95B26P00013
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The purpose of this $24,999.00 contract is to procure neural recording probes from Neuronexus that will be used for implanting into rat brains as part of the agency's research efforts. The contract has an ultimate completion date of December 9, 2025. Neuronexus is a...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The $23,736.41 contract is for the administrative de-obligation of unexpended and expiring Fiscal Year 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds, as required by 31 U.S.C. Section 1552(a). The contract is for the...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for the customization of software, hardware, and probe modification to enable implantation into rat brains and neural recordings in support of NIDA's biomedical research mission. Performance will...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to customize software, hardware, and probes for use in implanting devices into rat brains and conducting neural recordings. The contract supports research being conducted by Dr. Schoenbaum at the National Institute on Drug Abuse, part of the Department of Health and Human Services, to advance understanding of...
- This federal contract award from the National Institute of Environmental Health Sciences (NIEHS) is for the procurement of MICROELECTRODE products from Neuronexus Technologies, Inc., doing business as Nuvectra. The $32,685.89 firm fixed-price purchase order contract does not have a set-aside designation. Neuronexus Technologies, a for-profit manufacturer of advanced neuroscience research equipment, has been awarded this contract to provide specialized neural interface products, including...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $24,232.52 firm fixed-price purchase order by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to deliver X-HEADSTAGE-X6R128-UHDMI-M-ACC neuroscience research equipment. As the prime contractor, Nuvectra will provide the specified headstage products to support the NIH institute's biomedical research efforts. No subcontractors or set-aside designations were...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a firm fixed price purchase order valued at twenty-five thousand dollars by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, Nuvectra will customize software, hardware, and neural probes for implanting into rat brains and conducting neural recordings over a one year period ending in September 2024. The goal of this work supports the National Institute on Drug Abuse's broader...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $75,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide an X-DAQ ONE Series electrophysiology recording system, including hardware, software, and silicon recording probes, to support NIDA's biomedical research efforts. Performance...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse, a component of the National Institutes of Health within the Department of Health and Human Services. Under the contract, Nuvectra will provide Microelectrode PCB Adaptors and Passive Commutators to support scientific research. The adaptors and commutators will facilitate HDMI and UHDMI connections for use with X-Series equipment....
- <p>The National Institute of Mental Health (NIMH), a civilian federal agency, has awarded a $11,675.00 firm-fixed-price purchase order contract to Ripple Neuro, LLC for the delivery of electrode recording (electronic) front ends and cables. The contract, which does not have a set-aside designation, has a period of performance ending on July 8, 2025. This contract award is not associated with a larger contract vehicle.</p>
Neuronexus Technologies, Inc. (also doing business as Nuvectra) was awarded a firm fixed-price purchase order valued at $24,097.09 by the National Institute of Mental Health (NIMH) on January 20, 2026. The contract, which carries no set-aside designation, is scheduled for completion by January 19, 2027, with performance taking place at the company's facility in Ann Arbor, Michigan. As a specialized manufacturer of advanced neuroscience research equipment, Neuronexus will deliver products or services aligned with NIMH's research objectives, likely involving neural recording technologies, microelectrodes, or data acquisition systems based on the company's core capabilities. This award represents a continuation of NIMH's partnership with Neuronexus, a vendor that has established itself as a reliable supplier of sophisticated electrophysiology and neural recording equipment to the National Institutes of Health community. The company's recent work has included more expansive grant-funded development projects with NIMH focused on creating integrated systems for large-scale neural recording and stimulation in human brain organoids, indicating that this purchase order may support either direct research needs or component requirements for the Institute's broader neuroscience research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 1/29/26 |